On ECHEMI
Home > Drugs > Chifeng Arker Pharmaceutical Technology Co., Ltd.
Chifeng Arker Pharmaceutical Technology Co., Ltd.
  • Founded in:

    2001-07-27
  • Country:

    China China
  • Address:

    No. 8, Mengxin Street, Hongshan Economic Development Zone, Chifeng, Inner Mongolia Autonomous Region
  • Tax NO.:

    91150400720172660N
  • Registered Funds:

    40.9 million yuan
  • Website:

  • Email:

Related Drugs
Nifedipine
Nifedipine
Name Description Content CAS NO. Registered Holders
Nifedipine

1. It can simultaneously relax the coronary arteries in the normal blood supply area and the ischemic area, antagonize spontaneous or ergonovine-induced coronary artery spasm, increase the delivery of myocardial oxygen to patients with coronary artery spasm, and relieve and prevent coronary artery spasm. 2. It can inhibit myocardial contraction, reduce myocardial metabolism, and reduce myocardial oxygen consumption. 3. It can relax peripheral resistance vessels, reduce peripheral resistance, and can reduce systolic and diastolic blood pressure, reducing cardiac afterload. 4. It can delay the sinus node function and atrioventricular conduction of isolated hearts; electrophysiological studies on whole animals and humans have not found that this product has the effect of delaying atrioventricular conduction, prolonging the recovery time of the sinus node, and slowing down the sinus node rate.

More

1. It can simultaneously relax the coronary arteries in the normal blood supply area and the ischemic area, antagonize spontaneous or ergonovine-induced coronary artery spasm, increase the delivery of myocardial oxygen to patients with coronary artery spasm, and relieve and prevent coronary artery spasm. 2. It can inhibit myocardial contraction, reduce myocardial metabolism, and reduce myocardial oxygen consumption. 3. It can relax peripheral resistance vessels, reduce peripheral resistance, and can reduce systolic and diastolic blood pressure, reducing cardiac afterload. 4. It can delay the sinus node function and atrioventricular conduction of isolated hearts; electrophysiological studies on whole animals and humans have not found that this product has the effect of delaying atrioventricular conduction, prolonging the recovery time of the sinus node, and slowing down the sinus node rate.

21829-25-4 75
Dextromethorphan Hydrobromide
Name Description Content CAS NO. Registered Holders
Dextromethorphan hydrobromide monohydrate

Extract from the above information

More

Extract from the above information

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.